Liquamox® C IS
Synergistic Antibiotic Combination with Broad Spectrum Bacterial Resistance Inhibitor
Injectable Suspension
Amoxicillin (as Trihydrate) 14 g, Clavulanic Acid (as Potassium Clavulanate) 3.5 g
Treatment and prevention of infections caused by strains sensitive to the association amoxicillin + clavulanic acid (including those that produce beta-lactamases); among them: respiratory infections, urinary infections, gastrointestinal infections, periodontal infections and gingivitis, skin and soft tissue infections (e.g. abscesses, pyoderma, cellulitis, anal sacculitis and endocarditis)
Subcutaneous injectable: 1 mL/20 kg b.w daily.
Bottle x 50 mL , Bottle x 100 mL .
SENASA Registry: Reg. SENASA Perú: F.082.042.I.00719.
Print
Insert
ShareThis content is informative reference and should not be considered as prescriptions.
